Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma

被引：0
|
作者：
Szumera-Cieckiewicz, A. [1 ]
Sokol, K. [1 ,2 ]
Rymkiewicz, G. [2 ]
Paszkiewicz-Kozik, E. [3 ]
Poleszczuk, J. [4 ]
Borysiuk, A. [2 ]
Kotarska, M. [3 ]
Walewski, J. [3 ]
Prochorec-Sobieszek, M. [5 ]
机构：
[1] Inst Haematol & Transfus Med, Dept Diagnost Haematol, Warsaw, Poland
[2] Maria Sklodowska Curie Inst Oncol Ctr, Dept Pathol & Lab Med, Gliwice, Poland
[3] Maria Sklodowska Curie Inst Oncol Ctr, Dept Lymphoid Malignancies, Gliwice, Poland
[4] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, Warsaw, Poland
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-13-004
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Enhancer of zeste homolog 2 (EZH2) expression in bladder cancer
    Warrick, Joshua I.
    Raman, Jay D.
    Kaag, Matthew
    Bruggeman, Trey
    Cates, Justin
    Clark, Peter
    DeGraff, David J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 258.e1 - 258.e6
  • [2] Enhancer of zeste homolog 2 (EZH2) inhibitors
    Gulati, Nitya
    Beguelin, Wendy
    Giulino-Roth, Lisa
    LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1574 - 1585
  • [3] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
    Gong, Y.
    Chen, J.
    Wang, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    MODERN PATHOLOGY, 2013, 26 : 44A - 45A
  • [4] Expression of Enhancer of Zeste Homolog 2 (EZH2) in Invasive Neuroendocrine Carcinoma of the Breast
    Gong, Y.
    Chen, J.
    Wang, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    LABORATORY INVESTIGATION, 2013, 93 : 44A - 45A
  • [5] Expression of enhancer of zeste homolog 2 (EZH2) in Invasive neuroendocrine carcinoma of the breast
    Gong, Y.
    Chen, J.
    Radvanyi, L.
    Rosen, D. G.
    Wu, Y.
    HISTOPATHOLOGY, 2012, 61 : 20 - 20
  • [6] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    MODERN PATHOLOGY, 2010, 23 : 47A - 48A
  • [7] Positive Expression of Enhancer of Zeste Homolog 2 (EZH2) Predicts Shorter Overall Survival in Patients with Inflammatory Breast Cancer
    Gong, Y.
    Huo, L.
    Sneige, N.
    Cristofanilli, M.
    LABORATORY INVESTIGATION, 2010, 90 : 47A - 48A
  • [8] Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
    Ciarapica, Roberta
    Miele, Lucio
    Giordano, Antonio
    Locatelli, Franco
    Rota, Rossella
    BMC MEDICINE, 2011, 9
  • [9] Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas: first implications
    Roberta Ciarapica
    Lucio Miele
    Antonio Giordano
    Franco Locatelli
    Rossella Rota
    BMC Medicine, 9
  • [10] The significance of enhancer of zeste homolog 2 (EZH2) expression in spindle cell lesions of the breast
    Genco, Iskender Sinan
    Hackman, Kayla
    Morrar, Doaa
    Jin, Cao
    Santagada, Eugene
    Hajiyeva, Sabina
    PATHOLOGY INTERNATIONAL, 2021, 71 (06) : 415 - 419
12345